BioHarvest wins $20-30M fragrance manufacturing contract
Canadian biotech firm secures long-term deal with undisclosed global partner, expanding its production capacity in the fragrance sector.
BioHarvest Sciences Inc. has secured a manufacturing contract valued between $20 million and $30 million with an unnamed global fragrance company, the Canadian biotechnology firm said on Monday.
The agreement, which spans multiple years, marks a significant expansion for BioHarvest’s fragrance production capabilities. The company, which specializes in natural ingredient extraction and biomanufacturing, did not disclose the name of the partner but emphasized the long-term nature of the deal. Financial terms were not specified beyond the estimated contract value range.
BioHarvest’s chief executive officer, Ilan Sobel, stated that the contract aligns with the company’s strategy to leverage its proprietary fermentation technology for high-value fragrance compounds. The deal is expected to bolster BioHarvest’s revenue streams and enhance its position in the sustainable fragrance market.
The company, headquartered in Vancouver, has been expanding its biomanufacturing footprint in recent quarters, targeting applications in cosmetics, food ingredients, and fragrances. Analysts noted that the contract could serve as a catalyst for BioHarvest’s stock performance, though no immediate market reaction was observed.
Further details regarding the timeline for production commencement or the specific compounds involved were not provided.
Helena covers corporate news for listed and private companies across Europe, from strategy shifts to leadership changes, with an eye for what a story signals about the broader market.
More from Helena Vásquez →